Day: July 6, 2023

STEM insights from engineers and scientists pioneering Cannabis Image Cannabis News July 6, 2023 The foundations of this sector are science, technology, engineering, and mathematics. To prove it, we’re highlighting a few intrepid cannabis entrepreneurs using their background in STEM to innovate the emerging industry. Nohtal Partansky, Founder and CEO,Continue Reading

More than 200,000 signatures submitted to regulate tax Marijuana Image Cannabis News July 6, 2023 Ohioans may get a say on whether the state should legalize recreational marijuana. The Coalition to Regulate Marijuana Like Alcohol just submitted over 200,000 signatures for their proposal on the November ballot. If it passes,Continue Reading

New York Cannabis social equity fund secures $150 Million investment Image Cannabis News July 6, 2023 New York Governor Kathy Hochul announced last week that the state’s cannabis social equity fund has secured a $150 million investment from Chicago Atlantic. New York Governor Kathy Hochul last week announced that theContinue Reading

Matt Gaetz proposes to ban Marijuana testing in the US Military Image Cannabis News July 6, 2023 Matt Gaetz has introduced an amendment to the National Defense Authorization Act (NDAA) to ban marijuana testing for members of the military both during the processes of enlistment and when accepting a commission.Continue Reading

Overuse of Marijuana linked to surgery complications and death Image Cannabis News July 6, 2023 Clinical overuse of marijuana is linked to a variety of complications after major elective surgery, including blood clots, stroke, breathing difficulties, kidney issues and even death, a new study found. “Our findings complement previous studiesContinue Reading

Weed sales in decline in largest drop since legalization Image Cannabis News July 6, 2023 Denver reported a 22% decline in marijuana sales from 2021 to 2022 as weed sales cool across the state. DENVER — Denver’s weed sales are coming down from a high – and they’re coming downContinue Reading

The US Food and Drug Administration (FDA) has issued new draft guidance that highlights key considerations for researchers conducting clinical trials of psychedelic drugs for the treatment of medical conditions. The move, which was announced by the agency on June 23, marks the first time the FDA has issued guidanceContinue Reading